Editas Medicine Inc
NASDAQ:EDIT
ROA
Return on Assets
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
ROA Across Competitors
ROA Comparison
Editas Medicine Inc Competitors
Country | US |
Market Cap | 426.8m USD |
ROA |
-30%
|
Country | US |
Market Cap | 295.4B USD |
ROA |
4%
|
Country | US |
Market Cap | 144.2B USD |
ROA |
8%
|
Country | US |
Market Cap | 102.5B USD |
ROA |
18%
|
Country | US |
Market Cap | 97.4B USD |
ROA |
13%
|
Country | AU |
Market Cap | 134.5B AUD |
ROA |
7%
|
Country | US |
Market Cap | 81.3B USD |
ROA |
9%
|
Country | US |
Market Cap | 43.1B USD |
ROA |
-21%
|
Country | US |
Market Cap | 40.6B USD |
ROA |
-21%
|
Country | US |
Market Cap | 29.3B USD |
ROA |
5%
|
Country | KR |
Market Cap | 36.9T KRW |
ROA |
4%
|
Profitability Report
View the profitability report to see the full profitability analysis for Editas Medicine Inc.
See Also
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
Based on Editas Medicine Inc's most recent financial statements, the company has ROA of -30.2%.